BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 6975352)

  • 1. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody studies in B-cell chronic lymphocytic leukemia and allied disorders.
    Aisenberg AC; Wilkes BM
    Hematol Oncol; 1983; 1(1):13-9. PubMed ID: 6610619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface markers on leukemia and lymphoma cells: recent advances.
    Foon KA; Schroff RW; Gale RP
    Blood; 1982 Jul; 60(1):1-19. PubMed ID: 6805534
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell surface phenotype in lymphoproliferative disease.
    Aisenberg AC; Wilkes BM; Long JC; Harris NL
    Am J Med; 1980 Feb; 68(2):206-13. PubMed ID: 6965562
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic characterization of a helper T-cell lymphoma.
    Gramatzki M; Dolan MF; Fauci AS; Maples JA; Bonnard GD; Strong DM
    Blood; 1982 Apr; 59(4):702-8. PubMed ID: 6977388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.
    Kamoun M; Kadin ME; Martin PJ; Nettleton J; Hansen JA
    J Immunol; 1981 Sep; 127(3):987-91. PubMed ID: 6790625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic classification of leukemia and lymphoma.
    Foon KA; Todd RF
    Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte "receptors".
    Verbi W; Greaves MF; Schneider C; Koubek K; Janossy G; Stein H; Kung P; Goldstein G
    Eur J Immunol; 1982 Jan; 12(1):81-6. PubMed ID: 6977453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody analysis of T cell subsets in 40 patients with immunodeficiencies.
    Aiuti F; Pandolfi F; Fiorilli M; Bonomo R; Quinti I; Frielingsdorf A; Luzi G
    J Clin Immunol; 1982 Jul; 2(3 Suppl):81S-89S. PubMed ID: 6215427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of monoclonal antibodies in hematology].
    Pagnucco G; Bernasconi C
    Riv Emoter Immunoematol; 1984; 31(1):1-35. PubMed ID: 6085185
    [No Abstract]   [Full Text] [Related]  

  • 14. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
    Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
    Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of immunological phenotypes of lymphoblastic lymphoma.
    Cossman J; Chused TM; Fisher RI; Magrath I; Bollum F; Jaffe ES
    Cancer Res; 1983 Sep; 43(9):4486-90. PubMed ID: 6191861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
    Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
    Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of subpopulations of T lymphocytes and Ia positive B lymphocytes using a rosette assay based upon the biotin-avidin interaction.
    Mason RJ; Stewart KN; Power DA; MacLeod AM; Catto GR
    Immunol Lett; 1983; 7(3):157-61. PubMed ID: 6607881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serological diagnosis of the antigenic markers of acute lymphatic leukaemias and non-Hodgkin lymphomas in childhood (author's transl)].
    Thränhardt H; Zintl F; Plenert W
    Arch Geschwulstforsch; 1978; 48(4):289-300. PubMed ID: 308796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosette formation with mouse erythrocytes: probable marker for human B lymphocytes.
    Gupta S; Grieco MH
    Int Arch Allergy Appl Immunol; 1975; 49(6):734-42. PubMed ID: 1081075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia B-lymphocytes forming SRBC-rosettes not due to an anti-SRBC activity of monoclonal surface immunoglobulin.
    Herrmann F; Kolecki P; Sieber G; Ludwig WD; Komischke B; Rühl H
    Am J Clin Pathol; 1985 Feb; 83(2):249-53. PubMed ID: 3871584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.